Age (year) |
63.7 ± 9.7 |
65.3 ± 9.9 |
0.085 |
Female, n (%) |
20 (20.6%) |
93 (31.2%) |
0.028 |
BMI (kg/m2) |
24.0 ± 3.1 |
24.1 ± 3.5 |
0.485 |
PAF Disease Duration (months) |
24.9 ± 42.2 |
32.1 ± 33.5 |
0.023 |
HT, n (%) |
51 (52.6%) |
159 (53.4%) |
0.493 |
CHF, n (%) |
2 (2.1%) |
14 (4.7%) |
0.203 |
DM, n (%) |
13 (13.4%) |
30 (10.1%) |
0.230 |
Previous stroke or TIA, n (%) |
1 (1.0%) |
10 (3.4%) |
0.202 |
Vascular disease, n (%) |
1 (1.0%) |
17 (5.7%) |
0.055 |
CHA2DS2-VASc score |
1.51 ± 1.13 |
1.94
± 1.26 |
0.010 |
T-cho (mg/dl) |
199.3 ± 34.5 |
190.9 ± 32.8 |
0.523 |
LDL-cho (mg/dl) |
114.4 ± 29.9 |
108.4 ± 28.3 |
0.958 |
Hba1c (%) |
5.9 ± 0.6 |
5.9 ± 0.7 |
0.509 |
BNP (pg/ml) |
45.2 ± 43.0 |
53.3 ± 46.9 |
0.081 |
Ccr (ml/min) |
83.7 ± 23.1 |
77.4 ± 27.7 |
0.036 |
Echocardiographic Data |
|
|
|
LAD (mm) |
40.6 ± 5.9 |
41.0 ± 6.0 |
0.709 |
LA area (×102 mm2) |
20.2 ± 5.4 |
21.4 ± 5.5 |
0.035 |
EF (%) |
65.5 ± 8.4 |
65.8 ± 7.7 |
0.863 |
Catheter ablation procedure |
|
|
|
Additional SVC/PLA ablation |
24 (24.7%) |
102 (34.2%) |
0.082 |